Principal Financial Group Inc. Boosts Stake in Astrana Health, Inc. $ASTH

Posted by on Jul 28th, 2026

Principal Financial Group Inc. lifted its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 15.7% in the first quarter, according to its most recent filing with the SEC. The fund owned 265,948 shares of the company’s stock after acquiring an additional 36,150 shares during the period. Principal Financial Group Inc.’s holdings in Astrana Health were worth $6,521,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ASTH. Royal Bank of Canada increased its stake in Astrana Health by 6.5% in the first quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after acquiring an additional 17,028 shares during the last quarter. AQR Capital Management LLC bought a new stake in Astrana Health during the first quarter worth about $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Astrana Health by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after purchasing an additional 1,263 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Astrana Health by 4,365.2% in the 1st quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock worth $346,000 after purchasing an additional 10,913 shares in the last quarter. Finally, Intech Investment Management LLC boosted its holdings in shares of Astrana Health by 5.8% in the 1st quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock worth $1,383,000 after purchasing an additional 2,462 shares in the last quarter. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Trading Down 5.3%

NASDAQ ASTH opened at $38.19 on Tuesday. Astrana Health, Inc. has a 1-year low of $18.08 and a 1-year high of $51.60. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. The stock has a 50-day moving average of $41.76 and a 200-day moving average of $31.97. The firm has a market cap of $2.13 billion, a PE ratio of 62.61 and a beta of 0.89.

Astrana Health (NASDAQ:ASTH – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.45. The business had revenue of $965.10 million for the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.Astrana Health’s revenue for the quarter was up 55.6% compared to the same quarter last year. During the same period last year, the company earned $0.42 EPS. As a group, sell-side analysts forecast that Astrana Health, Inc. will post 1.25 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have recently commented on ASTH. Needham & Company LLC increased their price objective on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Robert W. Baird set a $45.00 target price on Astrana Health in a research report on Friday, May 8th. BTIG Research upped their target price on Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Truist Financial increased their price target on shares of Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a research report on Thursday, May 14th. Finally, Barclays raised shares of Astrana Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $37.00 to $50.00 in a research note on Tuesday, May 26th. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $47.86.

View Our Latest Research Report on ASTH

About Astrana Health

(Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Featured Articles

Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTH – Free Report).

Institutional Ownership by Quarter for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.